India Glycols after the demerger: focus sharpens as margins expand

The presentation states the demerger became effective on 1 September 2026 and the record date was 2 September 2026.

India Glycols retains Bio-based Specialty Materials, Sustainable and Performance Chemicals, and Gases, along with Novel Tech initiatives.

For FY26, the presentation shows Bio-based Specialty Materials INR 546 crore, Sustainable and Performance Chemicals INR 474 crore, and Gases INR 46 crore.

The National Company Law Tribunal order states shareholders receive 1 IGL Spirits share for every 1 India Glycols share, and 1 Ennature Biopharma share for every 3 India Glycols shares, subject to the record date.

Net sales are shown as INR 1,581 crore in FY24, INR 1,291 crore in FY25, and INR 1,164 crore in FY26. Adjusted EBITDA margin is shown as 15.6% in FY24, 24.2% in FY25, and 28.4% in FY26.

The presentation shows FY26 sales to the joint venture of INR 419 crore, FY26 sales volume of about 34,000 metric tonnes, and joint venture profit after tax of INR 95 crore.